Professor, Medicine, UCSF School of Medicine; Director, Heart Failure and Director, Echocardiography, SFVAMC
Cardiology
Dr. John R. Teerlink, MD
|
|
Give Review
Doctor John R. Teerlink, MD works in the field of Cardiology. He attended Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 1 awards "Fellow (FACC)". John R. Teerlink, MD is a published doctor as well. He has 100 publications published. The latest was: Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients.
Publications
- MicroRNAs relate to early worsening of renal function in patients with Acute heart failure.
- The first prognostic model for stroke and death in patients with systolic Heart failure.
- Omecamtiv mecarbil: a novel cardiac myosin activator for the treatment of Heart failure.
- Letter by Teerlink et al Regarding Article, "Myosin Activator Omecamtiv Mecarbil Increases Myocardial Oxygen Consumption and Impairs Cardiac Efficiency Mediated by Res...
- Plasma kidney injury molecule-1 in Heart failure: renal mechanisms and clinical outcome.
- In-hospital worsening Heart failure.
- Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
- Acute Heart Failure in the Elderly: Differences in Clinical Characteristics, Outcomes, and Prognostic Factors in the VERITAS Study.
- Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor: Rationale and Design of the BLAST-AHF Study (Biased Ligand of the Angi...
- Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with Heart failure.
- Early management of patients with Acute heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/he...
- Worsening heart failure, a critical event during hospital admission for Acute heart failure: results from the VERITAS study.
- Serelaxin : a potential new drug for the treatment of Acute heart failure.
- Novel drug mechanisms in development for Heart failure.
- International differences in clinical characteristics, management, and outcomes in Acute heart failure patients: better short-term outcomes in patients enrolled in Eas...
- Developing Therapies for Heart Failure With Preserved Ejection Fraction: Current State and Future Directions.
- Associations of Tissue Doppler Imaging with NT-proBNP and hs-TnT: A Pilot Study in End-Stage Renal Disease.
- Site selection in global clinical trials in patients hospitalized for Heart failure: perceived problems and potential solutions.
- Determinants of hemodialysis-induced segmental wall motion abnormalities.
- Acute Decompensated Heart Failure Update.
- Association of segmental wall motion abnormalities occurring during hemodialysis with post-dialysis fatigue.
- What's New in the Treatment of Acute Heart Failure?
- Strategies to prevent postdischarge adverse events among hospitalized patients with Heart failure.
- Benefit of Warfarin Compared with Aspirin in Heart Failure Patients in Sinus Rhythm: A Subgroup Analysis of WARCEF, a Randomized Controlled Trial.
- Do countries or hospitals with longer hospital stays for Acute heart failure have lower readmission rates?: Findings from ASCEND-HF.
- Predictors of early dyspnoea relief in Acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
- Serelaxin, recombinant human relaxin-2, for treatment of Acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
- Running from her past: a case of rapidly progressive dyspnea on exertion.
- Update on the Management of Acute Decompensated Heart Failure.
- Impact of serial troponin release on outcomes in patients with Acute heart failure: analysis from the PROTECT pilot study.
- Application of Adaptive Design and Decision Making to a Phase II Trial of a Phosphodiesterase Inhibitor for the Treatment of Intermittent Claudication.
- Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction Results From PROTECT (Placeb...
- Mind or body: comment on "tai chi exercise in patients with chronic Heart failure".
- Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF.
- Cardiac inotropes: current agents and future directions.
- Early dyspnoea relief in Acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
- Clinical development of pharmacologic agents for Acute heart failure syndromes: a proposal for a mechanistic translational phase.
- Relaxin: review of biology and potential role in treating Heart failure.
- A novel approach to improve cardiac performance: cardiac myosin activators.
- Relaxin, a pleiotropic vasodilator for the treatment of Heart failure.
- Agents with inotropic properties for the management of Acute heart failure syndromes. Traditional agents and beyond.
- Vasodilators in the treatment of Acute heart failure: what we know, what we don't.
- Investigating pain in Heart failure patients: rationale and design of the Pain Assessment, Incidence & Nature in Heart Failure (PAIN-HF) study.
- Learning the points of COMPASS-HF: assessing implantable hemodynamic monitoring in Heart failure patients.
- Acute heart failure: emerging from the shadows.
- Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction.
- COMPARE: comparison of the effects of carvedilol CR and carvedilol IR on left ventricular ejection fraction in patients with Heart failure.
- Comparison of pyrroloquinoline quinone and/or metoprolol on Myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
- Endothelins: pathophysiology and treatment implications in chronic Heart failure.
- Pharmacology of new agents for Acute heart failure syndromes.
- Overview of randomized clinical trials in Acute heart failure syndromes.
- The addition of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors--what has time told us?
- Nesiritide and worsening of renal function: the emperor's new clothes?
- Pyrroloquinoline quinone (PQQ) decreases Myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion.
- A rational approach for the treatment of Acute heart failure: current strategies and future options.
- Novel Pharmacologic Therapy of Heart Failure.
- Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for Acute decompensated heart failure.
- Design considerations and proposed template for clinical trials in hospitalized patients with decompensated chronic Heart failure.
- Dyspnea as an end point in clinical trials of therapies for Acute decompensated heart failure.
- Surrogate end points in Heart failure trials.
- Reversal of left ventricular remodeling: role of the endothelin pathway.
- Recent Heart failure trials of neurohormonal modulation (OVERTURE and ENABLE): approaching the asymptote of efficacy?
- Ventricular remodeling surgery for Heart failure: small animals and how to measure an improvement in ventricular function.
- The role of endothelin in the pathogenesis of Heart failure.
- Left ventricular volume reduction by radiofrequency heating of chronic myocardial infarction in patients with Congestive heart failure.
- Cognitive Function in Ambulatory Patients with Systolic Heart Failure: Insights from the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial.
- Acute heart failure syndromes and coronary perfusion.
- National Heart, Lung, and Blood Institute working group on emergency department management of Acute heart failure: research challenges and opportunities.
- Tezosentan in patients with Acute heart failure and Acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4).
- Late breaking Heart failure trials from the 2003 ACC meeting: EPHESUS and COMPANION.
- A proposal to standardize dyspnoea measurement in clinical trials of Acute heart failure syndromes: the need for a uniform approach.
- Nesiritide: a reappraisal of efficacy and safety.
- Ultrafiltration versus intravenous diuretics for patients hospitalized for Acute decompensated heart failure.
- Effects of tezosentan on symptoms and clinical outcomes in patients with Acute heart failure: the VERITAS randomized controlled trials.
- Dyspnoea in patients with Acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.
- Mode of death in patients with Heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-...
- Clinical trials of pharmacological therapies in Acute heart failure syndromes: lessons learned and directions forward.
- Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated Heart failure: results from UNLOAD.
- Relaxin for the treatment of patients with Acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb s...
- Phase III clinical trial end points in Acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group.
- Effects of tolvaptan on dyspnoea relief from the EVEREST trials.
- Hospital costs for treatment of Acute heart failure: economic analysis of the REVIVE II study.
- Dyspnoea and worsening heart failure in patients with Acute heart failure: results from the Pre-RELAX-AHF study.
- Ivabradine in Heart failure--no paradigm SHIFT…yet.
- Acute heart failure clinical drug development: from planning to proof of activity to phase III.
- Rolofylline, an adenosine A1-receptor antagonist, in Acute heart failure.
- Low lymphocyte ratio as a novel prognostic factor in Acute heart failure: results from the Pre-RELAX-AHF study.
- HFSA 2010 Comprehensive Heart Failure Practice Guideline.
- Role of tolvaptan in Acute decompensated heart failure.
- Early drop in systolic blood pressure and worsening renal function in Acute heart failure: renal results of Pre-RELAX-AHF.
- Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic Heart failure.
- Tezosentan in patients with Acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
- The development of new medical treatments for Acute decompensated heart failure.
- The Safety of an Adenosine A(1)-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment: Findings from PROTECT.
- Neurohormonal activation in Acute heart failure: results from VERITAS.
- Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study.
- The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic Heart failure: a double-blind, placebo-controlled, crossover, dose-ran...
- Medical therapy for chronic Heart failure.
- Procalcitonin-based indication of bacterial infection identifies high risk Acute heart failure patients.
Schools
Harvard Medical School
Uc San Francisco Med Center
F Hoffman Laroche
Howard Hughes Med Institute
Procedures Preformed
- Cardiac Imaging
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomegaly
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna
- Cigna
- Commercial Insurance Company
- Delta Health System
- Medicare MCR
- Mutual of Omaha
- United Healthcare
Awards
- Fellow (FACC)
Education
-
UCSF -
Harvard Medical School
Hospital
-
San Francisco VA Medical Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Vishal G. Patel, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Krishan V. Soni, MD |
|
Dr. Benedict P. Ancock, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Liviu Klein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kirsten E. Fleischmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew Rosenblatt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward J. McNulty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael H. Crawford, MD |
|
|
Dr. Keith E. Cohn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David W. Schopfer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajni K. Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Judith A. Wisneski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony Defrance, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Ebinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fady I. Malik, MD |
|
|
Dr. Lakshmi Sridharan, MD
This Doctor is OpenDoctor Recommended.
|